Position
Fidelity in CG Oncology, Inc.
Back to the book · All holders of CGON
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $12.7M$67.68 → $71.05
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.3M | $178.5M | — | — | — | 0.0% |
| Q1 2026 | 3.76M | $254.8M | $67.68 | $98.5M | −$22.1M | 0.0% |
| Q2 2026 | 4.16M | $295.7M | $71.05 | $12.7M | $28.2M | 0.0% |